PROBIOTIX HEALTH LS-05
ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. It offers various products, including YourBiotixMH for menopause health; YourBiotixPMH for post-menopause health; YourBiotixCH for cholesterol maintenance; YourBiotixCH InstaMelt for cholesterol health; YourBiotixBP for blood press… Read more
PROBIOTIX HEALTH LS-05 (X90) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, PROBIOTIX HEALTH LS-05 (X90) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
PROBIOTIX HEALTH LS-05 - Net Assets Trend (None–None)
This chart illustrates how PROBIOTIX HEALTH LS-05's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PROBIOTIX HEALTH LS-05 (None–None)
The table below shows the annual net assets of PROBIOTIX HEALTH LS-05 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to PROBIOTIX HEALTH LS-05's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
PROBIOTIX HEALTH LS-05 Competitors by Market Cap
The table below lists competitors of PROBIOTIX HEALTH LS-05 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nam Sung
KO:004270
|
$7.59 Million |
|
Sahathai Printing & Packaging PCL
BK:STP
|
$7.59 Million |
|
Kalamazoo Resources Limited
PINK:KAMRF
|
$7.60 Million |
|
Beyond Air Inc
NASDAQ:XAIR
|
$7.60 Million |
|
AnorTech Inc.
V:ANOR
|
$7.59 Million |
|
Hong Ha Son La Processing Agricutural Product JSC
VN:HSL
|
$7.59 Million |
|
PARKER-HANNIFIN CO. - Dusseldorf Stock Exchang
DU:PAR
|
$7.58 Million |
|
Dyandra Media International PT
JK:DYAN
|
$7.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PROBIOTIX HEALTH LS-05's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares PROBIOTIX HEALTH LS-05's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently PROBIOTIX HEALTH LS-05 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares PROBIOTIX HEALTH LS-05's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,345,847,517
- Average return on equity (ROE) among peers: -601.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PROBIOTIX HEALTH LS-05 (X90) | €- | N/A | N/A | $7.59 Million |
| 09R (09R) | $5.86 Million | -145.33% | 0.68x | $12.96 Million |
| IDORSIA AG (19T) | $104.20 Million | -608.99% | 13.23x | $582.75 Million |
| 1S90 (1S90) | $10.78 Million | -2319.92% | 31.35x | $54.21 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.28 Million |
| 25K0 (25K0) | $-79.67 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $508.00K | -2193.11% | 12.24x | $9.80 Million |
| Intervacc AB (publ) (2E9) | $308.25 Million | -9.53% | 0.07x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $3.03 Million | -558.03% | 2.82x | $9.20 Million |
| GNI Group Ltd (3G6) | $13.10 Billion | 1.39% | 0.57x | $772.60 Million |